Abstract

AYURVEDIC MANAGEMENT OF HEPATITIS B - A CASE STUDY

Dr. Kavita Sutagatti Md (Ayu), *Dr. Pallavi Jain Bams and Dr. Jeenu Kamboj Bams

.

Abstract

HBsAg, commonly known as the Australia antigen, is the surface antigen of the hepatitis B virus (HBV). It implies a current hepatitis B infection. Hepatitis B is a liver infection caused by the hepatitis B virus. It can be acute and self-resolving, or persistent, progressing to cirrhosis and liver cancer. Clinical symptoms such as yellow staining of urine, sclera, mucous membrane, and skin are similar to those of Kamala as described in Ayurveda. HBV is a significant global health issue. In 2015, around 887,000 persons worldwide died due to HBVrelated liver disease. Most adults with HBV experience a short-term disease that may not cause permanent damage. However, 2 to 6% of those infected may acquire a chronic infection that can lead to liver cancer. Around 90% of newborns infected with the virus acquire a persistent illness. Although there is no cure for HBV, immunization can help prevent an initial infection. Antiviral medications can be used to treat persistent infections. Kamala is treated with medications containing pitta shamaka rasas and deepana-pachana guna, which convert sama-pitta to nirama-pitta. It is quite significant in the samprapti vighatana of the Kamala sickness. The subclinical case discussed in this article was managed using the same guidelines as Kamala Chikitsa, and the outcomes were obtained. Ayurvedic treatment for Hepatitis B is far more effective and efficient.

Keywords: Hepatitis B, Kamala, Sama-pitta, Antiviral drugs.